VVOS – vivos therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
Vivos Therapeutics (NASDAQ:VVOS) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Vivos Therapeutics, Inc. For: Apr 03
Form 4 Vivos Therapeutics, Inc. For: Mar 31 Filed by: Skaff Michael C
Form SCHEDULE 13D Vivos Therapeutics, Inc. Filed by: V-Co Investors 3 LLC
Form NT 10-K Vivos Therapeutics, Inc. For: Dec 31
Form S-3 Vivos Therapeutics, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.